Nicole Arndt | Senior Manager, IR |
Ryan Spencer | CEO |
Donn Casale | SVP, Commercial |
Rob Janssen | Chief Medical Officer |
Kelly MacDonald | CFO |
Phil Nadeau | Cowen & Company |
Madhu Kumar | Goldman Sachs |
Matthew Phipps | William Blair |
Roy Buchanan | JMP Securities |
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies Fourth Quarter and Full Year 2022 Financial Results.
As a reminder, this conference call is being recorded. At the end of the Company’s prepared remarks, we will open the call for questions and provide specific instructions at that point.
I would now like to turn the call over to Nicole Arndt, Senior Manager, Investor Relations.
You may begin.